India Records Better Child Nutrition and Higher Institutional Births, National Survey Finds

Date:

Share post:

The Ministry of Health and Family Welfare has released the key findings of the Sixth Round of the National Family Health Survey (NFHS-6), 2023-24. Executed independently by the International Institute for Population Sciences (IIPS) across 679,238 households, NFHS-6 provides vital data to track India’s progress toward United Nations Sustainable Development Goals.

It was seen that the demographics & welfare rate of thepopulation aged 60+ grew to 12.9%. Health insurance coverage saw a massive surge, rising from 41.0% in NFHS-5 to 60.2%.The Total Fertility Rate stabilized at 2.0. Women marrying before the legal age of 18 dropped nationally to 20.1%.In maternal care it was seen , institutional deliveries reached 90.6%. However, Caesarean sections jumped to 27.2% nationally, soaring to 54.1% in private facilities. Full immunizationbin children rose to 82.6%. Child stunting dropped sharply from 35.5% to 29.3%Obesity rose to 30.7% for women and 27.3% for men, alongside a spike in high blood sugar levels. 

Divergent state trends emerged. Andhra Pradesh led in health insurance (91.9%) but faced high C-section rates (52.2%). Bihar showed remarkable nutritional recovery, cutting child stunting to 35.6%. Assam significantly reduced child marriage to 25.3%, while Arunachal Pradesh achieved 98.2% household electricity connectivity.

Union Health Minister Jagat Prakash Nadda noted that NFHS-6 will critically enable policymakers to formulate informed, corrective interventions at state and national levels.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

CDSCO Advises Pharma Companies to Track and Report Drug Side Effects

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued a firm directive to all medicine...

Emcure and Roche Collaborate to Improve Access to Advanced Nephrology Care

Emcure Pharmaceuticals has entered into a distribution agreement with Roche India for select products in nephrology and transplantation,...

India’s Lupin and Natco Pharma Secure U.S. FDA Approval for Eribulin Mesylate Injection

On 03rd June, 2026 Lupin Limited (Lupin) announced that, Lupin and its alliance partner Natco Pharma Limited (Natco) got the approval from the United States...

Alkem Launches India’s First Semaglutide Pre-Filled Syringes at Just INR 350

Alkem Laboratories Ltd. a leading Indian pharmaceutical company, today announced the groundbreaking launch of semaglutide in multiple dose...